New type of flu-vaccine FDA-approved
A new type of flu-vaccine from Novartis has been approved by the FDA. The US health authorities have also contributed to the expensive, new technology, which makes it possible to stock up faster than previously.
by Stefan Singh Kailay
In 2006 Novartis won a 220-million-dollar contract from the US health authorities concerning the development of a new type of flu, and in 2009 the same authorities invested 487 million dollars in the company’s US production facilities.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app
